News for hackers. Stuff that matters.
Re:Breakthrough drug trial saw cancer vanish in every patien... by tominous on Friday April 05, 2024 @08:32PM (#39948914)
Immunostimulant is a reasonable way to put it: it takes the brakes off one part of the immune system. (Similarly, we call caffeine a central nervous system stimulant and it works by blocking adenosine, which is one of the brakes on brain activity.)

And it's not always specific to tumours. My wife's thyroid got wiped out. The endocrinologist said it was like bombing a paint factory: first a massive spike in thyroid hormones, then a crash as no more were produced.

More info on the potential side effects of immune checkpoint inhibitors: https://www.cancer.gov/about-cancer/treatment/types/immunoth...

Re:Breakthrough drug trial saw cancer vanish in every patien... by Kalanos on Saturday April 06, 2024 @11:53AM (#39953247)
sorry about your wife. an immunostimulant is more about enraging/activating the immune system, not intervening with its capabilities
Re:Breakthrough drug trial saw cancer vanish in every patien... by tominous on Saturday April 06, 2024 @08:53PM (#39957154)
If you're trying to say that immunostimulant is a term of art distinct from immune checkpoint inhibitor, then fair point.

But what it seems like you're saying is checkpoint inhibitors don't "enrage/activate" the immune system, and they only target tumours, and both points are misleading if not outright wrong.

Re:Breakthrough drug trial saw cancer vanish in every patien... by Kalanos on Tuesday April 16, 2024 @09:24AM (#40051567)
Yes, it's a different term and entirely separate category of drugs.

Checkpoint inhibitors cut the brakes. This reduces their ability to detect "self," and attack blindly.

What they don't do is poke immune cells with a stick to anger them like chemoattractants and cytokines. This approach can be used to signal, "hey, the tumor is over here." Causing them to attack more intelligently.

If you would like to learn more, I would recommend the books: (a) molecular biology of cancer; mechanisms, targets, and therapeutics, and (b) handbook of therapeutic biomarkers in cancer.